Literature DB >> 28731921

Loss of CDKN1C in a Recurrent Atypical Teratoid/Rhabdoid Tumor.

Dustin Tran1, Sandra Camelo-Piragua, Avneesh Gupta, Kate Gowans, Patricia L Robertson, Rajen Mody, Carl Koschmann.   

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a malignant tumor that is commonly associated with biallelic alterations of SMARCB1. Recurrent or refractory AT/RT has not been molecularly characterized as well. We present the case of a child with recurrent AT/RT who underwent clinically integrated molecular profiling (germline DNA and tumor DNA/RNA sequencing). This demonstrated a somatic lesion in CDKN1C alongside hallmark loss of SMARCB1. This data allowed us to explore potential personalized therapies for this patient and expose a molecular driver that may be involved in similar cases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28731921      PMCID: PMC5656519          DOI: 10.1097/MPH.0000000000000873

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  19 in total

Review 1.  CDKN1C mutations: two sides of the same coin.

Authors:  Thomas Eggermann; Gerhard Binder; Frédéric Brioude; Eamonn R Maher; Pablo Lapunzina; Maria Vittoria Cubellis; Ignacio Bergadá; Dirk Prawitt; Matthias Begemann
Journal:  Trends Mol Med       Date:  2014-09-25       Impact factor: 11.951

Review 2.  Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

Authors:  Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

Review 3.  Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Cancer Genet       Date:  2014-04-13

4.  Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.

Authors:  Robert G J Vries; Vladimir Bezrookove; Lobke M P Zuijderduijn; Sima Kheradmand Kia; Ada Houweling; Igor Oruetxebarria; Anton K Raap; C Peter Verrijzer
Journal:  Genes Dev       Date:  2005-03-15       Impact factor: 11.361

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Peter M de Blank; Carol Kruchko; Claire M Petersen; Peter Liao; Jonathan L Finlay; Duncan S Stearns; Johannes E Wolff; Yingli Wolinsky; John J Letterio; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-01       Impact factor: 12.300

7.  Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.

Authors:  Seungjae Lee; Velasco Cimica; Nandini Ramachandra; David Zagzag; Ganjam V Kalpana
Journal:  Cancer Res       Date:  2011-04-26       Impact factor: 12.701

8.  Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.

Authors:  Qiu Rao; Qiu-yuan Xia; Zi-yu Wang; Li Li; Qin Shen; Shan-shan Shi; Xuan Wang; Biao Liu; Yan-fen Wang; Qun-li Shi; Heng-hui Ma; Zhen-feng Lu; Yan He; Ru-song Zhang; Bo Yu; Xiao-jun Zhou
Journal:  Histopathology       Date:  2015-02-05       Impact factor: 5.087

9.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Authors:  Joanne M Hilden; Sharon Meerbaum; Peter Burger; Jonathan Finlay; Anna Janss; Bernd W Scheithauer; Andrew W Walter; Lucy B Rorke; Jaclyn A Biegel
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

10.  Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

Authors:  Roger J Packer; Jaclyn A Biegel; Susan Blaney; Jonathan Finlay; J Russell Geyer; Richard Heideman; Joanne Hilden; Anna J Janss; Larry Kun; Gilbert Vezina; Lucy B Rorke; Malcolm Smith
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.